^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TQ-B3234

    i
    Associations
    News

    Trials

    Company:
    Sino Biopharm
    Drug class:
    MEK1 inhibitor, MEK2 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis (NCT05107037)
    Phase 1
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
    Not yet recruiting
    Last update posted :
    11/04/2021
    Initiation :
    11/01/2021
    Primary completion :
    12/01/2023
    Completion :
    12/01/2024
    NF1
    |
    NF1 mutation
    |
    TQ-B3234